STOCK TITAN

Electromed - ELMD STOCK NEWS

Welcome to our dedicated page for Electromed news (Ticker: ELMD), a resource for investors and traders seeking the latest updates and insights on Electromed stock.

Electromed Inc. (ELMD) specializes in advanced airway clearance solutions through its clinically validated SmartVest system. This dedicated news hub provides investors and healthcare stakeholders with essential updates on respiratory care innovations, regulatory compliance, and corporate developments.

Find authoritative coverage of ELMD's progress in HFCWO technology, including product enhancements, partnership announcements, and quality certifications. Our curated news selection emphasizes factual reporting on clinical trial outcomes and market expansion initiatives within the medical device sector.

Regular updates include earnings disclosures, manufacturing quality milestones, and research collaborations. Bookmark this resource for streamlined access to verified ELMD developments that impact respiratory therapy standards and investment considerations.

Rhea-AI Summary

Electromed, Inc. has appointed Christopher Holland as Chief Commercial Officer to spearhead its strategic growth initiatives. With 30 years of experience in the Medical Technology sector, Holland previously held significant roles at Prosomnus Sleep Technologies and Nonin Medical, where he drove substantial revenue growth. CEO Kathleen Skarvan expressed confidence in Holland's ability to enhance marketing and sales strategies that align with the company’s revenue goals and shareholder value. This leadership shift aims to position Electromed prominently within the airway clearance market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
management
-
Rhea-AI Summary

Electromed, Inc. (NYSE American: ELMD) reported record quarterly net revenues of $10.2 million for the fiscal second quarter ended December 31, 2021, up from $9.5 million year-over-year. Home care revenues drove this growth, totaling $9.4 million, despite a decline in gross profit margin to 76.9% due to rising raw material and shipping costs. Operating income decreased to $1.1 million, with net income at $0.8 million or $0.10 per diluted share. The company plans to continue strategic growth initiatives, including a focus on expanding its sales force and developing new product offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.77%
Tags
-
Rhea-AI Summary

Electromed, Inc. (AMEX: ELMD) announced that it will release its financial results for the fiscal 2022 second quarter, ending December 31, 2021, on February 8, 2022, after the market closes. A conference call to discuss these results will be held at 5:00 p.m. ET on the same day, accessible via phone for domestic and international callers. The event can also be streamed live on the Investor Relations section of their website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
Rhea-AI Summary

Electromed, a leader in airway clearance technologies, announced its participation in the Sidoti December Virtual Micro Cap Investor Conference on December 8-9, 2021. Key executives, including President Kathleen Skarvan and CFO Mike MacCourt, will present on December 8 at 2:30 p.m. Eastern Time and will be available for one-on-one meetings. Electromed is known for its SmartVest® Airway Clearance System, aimed at patients with compromised pulmonary function. The Company is based in New Prague, Minnesota, and has been operational since 1992.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.16%
Tags
conferences
-
Rhea-AI Summary

Electromed, Inc. (NYSE American: ELMD) reported a record quarterly revenue of $10.0 million for Q1 FY 2022, reflecting a 25.0% increase year-over-year. Growth was driven by a 24.4% rise in home care revenue to $9.3 million and a 61.5% increase in institutional revenue. Gross profit margin improved to 77.0% despite rising costs. However, net income declined to $439,000 or $0.05 per diluted share. SG&A expenses rose to $6.8 million due to strategic investments. The company maintains $11.0 million in cash and continues to focus on product development and digital marketing strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.24%
Tags
-
Rhea-AI Summary

Electromed, Inc. (AMEX: ELMD) will release its fiscal 2022 Q1 financial results on November 9, 2021, after market close. A conference call will follow at 5:00 p.m. Eastern Time to discuss these results. Interested parties can join via phone or through a live webcast available on the company’s website. Electromed is known for its innovative airway clearance technologies, particularly the SmartVest Airway Clearance System, catering to patients with compromised pulmonary function.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.28%
Tags
Rhea-AI Summary

Electromed, Inc. (NYSE: ELMD) has announced a cooperation agreement with Summers Value Partners, which holds 5.9% of its stock, leading to the nomination of two new independent directors, Kathy Tune and Joe Galatowitsch, for the upcoming Fiscal 2022 Annual Meeting. A new Finance and Strategy Committee will be formed to enhance value creation. Retiring board members Steve Craney and George Winn will leave their positions. The company highlighted its commitment to growth, showcasing a strategy that aims for double-digit revenue growth and profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
none
-
Rhea-AI Summary

Electromed, Inc. (AMEX: ELMD) has announced that its President and CEO, Kathleen Skarvan, along with CFO Mike MacCourt, will participate in the 2021 Colliers Institutional Investor Conference on September 9, 2021. The conference will be held virtually, highlighting the company’s commitment to engaging with investors and stakeholders. Electromed specializes in airway clearance technologies, notably the SmartVest® Airway Clearance System, to assist patients with compromised pulmonary function. The company is based in New Prague, Minnesota, and has been operational since 1992.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.73%
Tags
conferences
-
Rhea-AI Summary

Electromed reported strong Q4 FY 2021 results, with a net revenue increase of 37.7% to $9.5 million, driven by a 90.6% growth in institutional sales and 33.6% in home care. Despite revenue growth, operating income fell to $0.7 million from $1.3 million in Q4 FY 2020, affected by past government stimulus and increased SG&A expenses. For FY 2021, total revenue rose 10.1% to $35.8 million but net income declined to $2.4 million, or $0.27 per diluted share. Cash reserves were $11.9 million, bolstered by $3.1 million in operating cash flow.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.78%
Tags
Rhea-AI Summary

Electromed (NYSE American: ELMD) announced that it will release its fiscal 2021 fourth quarter financial results on August 24, 2021, post-market close. A conference call will follow at 5:00 PM ET to discuss the results. Participants can join via domestic and international dialing or through a live webcast available on the Investor Relations section of their website. The company specializes in airway clearance therapy products, including the SmartVest Airway Clearance System, supporting patients with compromised pulmonary function.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
Electromed

NYSE:ELMD

ELMD Rankings

ELMD Stock Data

195.01M
6.82M
20.54%
43.56%
2.44%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEW PRAGUE